Contribution of Whole-Genome Sequencing and Transcript Analysis to Decipher Retinal Diseases Associated with


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Apr 2022
Historique:
received: 07 03 2022
revised: 25 03 2022
accepted: 11 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Biallelic gene defects in MFSD8 are not only a cause of the late-infantile form of neuronal ceroid lipofuscinosis, but also of rare isolated retinal degeneration. We report clinical and genetic data of seven patients compound heterozygous or homozygous for variants in MFSD8, issued from a French cohort with inherited retinal degeneration, and two additional patients retrieved from a Swiss cohort. Next-generation sequencing of large panels combined with whole-genome sequencing allowed for the identification of twelve variants from which seven were novel. Among them were one deep intronic variant c.998+1669A>G, one large deletion encompassing exon 9 and 10, and a silent change c.750A>G. Transcript analysis performed on patients’ lymphoblastoid cell lines revealed the creation of a donor splice site by c.998+1669A>G, resulting in a 140 bp pseudoexon insertion in intron 10. Variant c.750A>G produced exon 8 skipping. In silico and in cellulo studies of these variants allowed us to assign the pathogenic effect, and showed that the combination of at least one severe variant with a moderate one leads to isolated retinal dystrophy, whereas the combination in trans of two severe variants is responsible for early onset severe retinal dystrophy in the context of late-infantile neuronal ceroid lipofuscinosis.

Identifiants

pubmed: 35457110
pii: ijms23084294
doi: 10.3390/ijms23084294
pmc: PMC9032189
pii:
doi:

Substances chimiques

MFSD8 protein, human 0
Membrane Transport Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Retina France
ID : 2019

Références

Br J Ophthalmol. 2019 Jan 24;:
pubmed: 30679166
Hum Mol Genet. 2015 Nov 1;24(21):6213-28
pubmed: 26307081
Neurogenetics. 2005 Sep;6(3):107-26
pubmed: 15965709
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):292-302
pubmed: 20811047
Nat Commun. 2020 Jul 3;11(1):3328
pubmed: 32620864
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4739-46
pubmed: 16303974
Doc Ophthalmol. 2019 Feb;138(1):55-70
pubmed: 30446867
Am J Ophthalmol. 2020 Mar;211:159-175
pubmed: 31812472
Am J Ophthalmol. 2004 Jul;138(1):55-63
pubmed: 15234282
PLoS One. 2014 Oct 15;9(10):e109576
pubmed: 25333361
Eur J Med Genet. 2014 Nov-Dec;57(11-12):607-12
pubmed: 25270050
Traffic. 2010 Jul 1;11(7):987-1000
pubmed: 20406422
Prog Retin Eye Res. 2014 Sep;42:1-26
pubmed: 24857951
Ophthalmology. 2015 Feb;122(2):326-34
pubmed: 25312043
Biochim Biophys Acta. 2012 Oct;1822(10):1617-28
pubmed: 22668694
JAMA Ophthalmol. 2021 Mar 1;139(3):278-291
pubmed: 33507216
Br J Ophthalmol. 2016 Jan;100(1):115-21
pubmed: 25770143
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):13
pubmed: 33576794
Ophthalmology. 2015 Jan;122(1):170-9
pubmed: 25227500
PLoS One. 2018 Dec 13;13(12):e0207958
pubmed: 30543658
Mol Genet Genomic Med. 2019 Feb;7(2):e00527
pubmed: 30548430
N Engl J Med. 2019 Oct 24;381(17):1644-1652
pubmed: 31597037
Mol Genet Metab. 2019 Feb;126(2):196-205
pubmed: 30301600
Am J Hum Genet. 2007 Jul;81(1):136-46
pubmed: 17564970
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1147-1157
pubmed: 30903310
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
Hum Mutat. 2009 Mar;30(3):E530-40
pubmed: 19177532
Int J Mol Sci. 2021 Jun 15;22(12):
pubmed: 34203883
Int J Mol Sci. 2022 Feb 18;23(4):
pubmed: 35216386
Br J Ophthalmol. 2017 Sep;101(9):1147-1154
pubmed: 28689169
Am J Ophthalmol. 2013 Jun;155(6):1075-1088.e13
pubmed: 23499370
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Ophthalmology. 2015 Feb;122(2):335-44
pubmed: 25444351
Am J Med Genet C Semin Med Genet. 2020 Sep;184(3):828-837
pubmed: 32893963
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
PLoS One. 2013 Aug 28;8(8):e73128
pubmed: 24015292
J Ophthalmol. 2021 Aug 17;2021:6684045
pubmed: 34457359
Biochim Biophys Acta. 2009 Apr;1793(4):697-709
pubmed: 19084560
Neurogenetics. 2009 Oct;10(4):307-11
pubmed: 19277732
JAMA Ophthalmol. 2021 Mar 1;139(3):339-343
pubmed: 33507209
Hum Mutat. 2020 Oct;41(10):1811-1829
pubmed: 32741062
Ophthalmic Genet. 2019 Apr;40(2):141-145
pubmed: 31006324
Science. 1974 Sep 6;185(4154):862-4
pubmed: 4843792
Eur J Paediatr Neurol. 2015 Jan;19(1):78-86
pubmed: 25439737
Invest Ophthalmol Vis Sci. 2014 Oct 09;55(11):7217-26
pubmed: 25301883
Arch Ophthalmol. 2001 Mar;119(3):359-69
pubmed: 11231769
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Ophthalmol Retina. 2020 Apr;4(4):433-445
pubmed: 31926949
Clin Genet. 2020 Mar;97(3):426-436
pubmed: 31721179
Arch Ophthalmol. 2012 Nov;130(11):1425-32
pubmed: 23143442
Hum Mol Genet. 2010 Nov 15;19(22):4497-514
pubmed: 20826447
Ophthalmology. 2012 Jun;119(6):1199-210
pubmed: 22449572
Cell Signal. 2020 Jun;70:109572
pubmed: 32087303
Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2237-41
pubmed: 26026925
Vision Res. 2008 Nov;48(26):2569-77
pubmed: 18289629
Mol Vis. 2010 Dec 03;16:2550-8
pubmed: 21151602
Brain. 2009 Mar;132(Pt 3):810-9
pubmed: 19201763
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33924840
Hum Mol Genet. 2021 Oct 13;30(21):1907-1918
pubmed: 34104971
Am J Ophthalmol. 2013 Sep;156(3):487-501.e1
pubmed: 23953153
Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):2906-2914
pubmed: 28586915
Ophthalmic Genet. 2017 May-Jun;38(3):252-259
pubmed: 27486012

Auteurs

Anaïs F Poncet (AF)

Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France.

Olivier Grunewald (O)

Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France.

Veronika Vaclavik (V)

University of Lausanne, Jules-Gonin Eye Hospital, 1004 Lausanne, Switzerland.
Cantonal Hospital, Department of Ophthalmology, 1700 Fribourg, Switzerland.

Isabelle Meunier (I)

National Reference Centre for Inherited Sensory Diseases, University of Montpellier, Montpellier University Hospital, Sensgene Care Network, ERN-EYE Network, F-34000 Montpellier, France.
Institute for Neurosciences of Montpellier (INM), University of Montpellier, INSERM, F-34000 Montpellier, France.

Isabelle Drumare (I)

Exploration de la Vision et Neuro-Ophtalmology, CHU de Lille, F-59000 Lille, France.

Valérie Pelletier (V)

Centre de Référence pour les Affections Rares en Génétique Ophtalmologiques, Hopitaux Universitaires de Strasbourg, F-67000 Strasbourg, France.

Béatrice Bocquet (B)

National Reference Centre for Inherited Sensory Diseases, University of Montpellier, Montpellier University Hospital, Sensgene Care Network, ERN-EYE Network, F-34000 Montpellier, France.
Institute for Neurosciences of Montpellier (INM), University of Montpellier, INSERM, F-34000 Montpellier, France.

Margarita G Todorova (MG)

Department of Ophthalmology, Cantonal Hospital, 9007 St. Gallen, Switzerland.
Department of Ophthalmology, University of Zürich, 8091 Zürich, Switzerland.
Department of Ophthalmology, University of Basel, 4056 Basel, Switzerland.

Anne-Gaëlle Le Moing (AG)

Department of Child Neurology, Amiens-Picardy University Hospital, F-80000 Amiens, France.

Aurore Devos (A)

Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France.

Daniel F Schorderet (DF)

Faculty of Biology and Medicine, University of Lausanne and Faculty of Life Sciences, Ecole Polytechnique Fédérale of Lausanne, 1004 Lausanne, Switzerland.

Florence Jobic (F)

Unité de Génétique Médicale et Oncogénétique, Centre Hospitalier Universitaire Amiens Picardie, F-80000 Amiens, France.

Sabine Defoort-Dhellemmes (S)

Exploration de la Vision et Neuro-Ophtalmology, CHU de Lille, F-59000 Lille, France.

Hélène Dollfus (H)

Centre de Référence pour les Affections Rares en Génétique Ophtalmologiques, Hopitaux Universitaires de Strasbourg, F-67000 Strasbourg, France.

Vasily M Smirnov (VM)

Exploration de la Vision et Neuro-Ophtalmology, CHU de Lille, F-59000 Lille, France.
Université de Lille, Faculté de Médecine, F-59000 Lille, France.

Claire-Marie Dhaenens (CM)

Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH